Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer
Xiaxia Niu(Lanzhou University), Hongmei Cui(University of Tennessee Health Science Center)
Cited by 20
Related Papers
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
|Frontiers in Pharmacology|2021|12